-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2014 to 2024.
- Enanta Pharmaceuticals Inc Costs and Expenses for the quarter ending December 31, 2024 was $40.5M, a 23.4% decline year-over-year.
- Enanta Pharmaceuticals Inc Costs and Expenses for the twelve months ending December 31, 2024 was $177M, a 18% decline year-over-year.
- Enanta Pharmaceuticals Inc annual Costs and Expenses for 2024 was $189M, a 12.5% decline from 2023.
- Enanta Pharmaceuticals Inc annual Costs and Expenses for 2023 was $216M, a 3.05% increase from 2022.
- Enanta Pharmaceuticals Inc annual Costs and Expenses for 2022 was $210M, a 1.63% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)